Revenue, last quarter
$106.1M
−1.6% vs same quarter last year
Net income
−$73.9M
−182.2% vs same quarter last year
EPS, diluted
−$1.03
−195.4% vs same quarter last year
Operating cash flow
$41.7M
−16.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $411.3M | $271.2M |
| FY24 | $358.7M | $23.4M |
| FY23 | $310.5M | $179.7M |
| FY22 | $331.3M | $220.3M |
| FY21 | $391.9M | $368.8M |
| FY20 | $336.8M | $293.8M |
| FY19 | $261M | $191M |
| FY18 | $261M | $406.3M |
| FY17 | $217.2M | $134.3M |
| FY16 | $133.6M | $59.5M |
| FY15 | $53.9M | −$18.8M |
| FY14 | $8.4M | −$168.5M |
| FY13 | $4.5M | −$170.7M |
| FY12 | $5.6M | −$18.5M |
| FY11 | $24.5M | −$115.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 74.8% | 39.8% | 65.9% |
| FY24 | 82.6% | 46.5% | 6.5% |
| FY23 | 79.2% | 36.7% | 57.9% |
| FY22 | - | - | 66.5% |
| FY21 | - | 95.7% | 94.1% |
| FY20 | - | 95.3% | 87.2% |
| FY19 | - | 94.4% | 73.2% |
| FY18 | - | 91.3% | 155.7% |
| FY17 | - | 84.5% | 61.8% |
| FY16 | - | 81.6% | 44.6% |
| FY15 | - | 58.5% | −34.8% |
| FY14 | - | −402.3% | −1997.7% |
| FY13 | - | −635.4% | −3766.6% |
| FY12 | - | −448% | −330.3% |
| FY11 | - | −447.7% | −470.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $195.8M |
| FY24 | $188.4M |
| FY23 | $140.7M |
| FY22 | $201.7M |
| FY21 | $363.8M |
| FY20 | $313.1M |
| FY19 | $257.4M |
| FY18 | $223.5M |
| FY17 | $141.7M |
| FY16 | $60.7M |
| FY15 | $10.1M |
| FY14 | −$131.4M |
| FY13 | −$132.3M |
| FY12 | −$130.1M |
| FY11 | −$92M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | - | $4.5M |
| FY24 | - | $14.8M |
| FY23 | - | $75.7M |
| FY22 | - | $8.5M |
| FY21 | $0 | $394.1M |
| FY20 | $0 | $0 |
| FY19 | $11K | $0 |
| FY18 | $80K | $0 |
| FY17 | $281K | $97.5M |
| FY16 | $960K | $78.1M |
| FY15 | $87.3M | $25.6M |
| FY14 | $57M | $0 |
| FY13 | $0 | $0 |
| FY12 | $0 | - |
| FY11 | - | - |
- Innoviva
- Healthcare median
Show the numbers
| Year | Innoviva | Healthcare median |
|---|---|---|
| FY25 | 65.9% | −30.6% |
| FY24 | 6.5% | −47% |
| FY23 | 57.9% | −58% |
| FY22 | 66.5% | −80.4% |
| FY21 | 94.1% | −71.8% |
| FY20 | 87.2% | −62.2% |
| FY19 | 73.2% | −46.2% |
| FY18 | 155.7% | −49.6% |
| FY17 | 61.8% | −45.9% |
| FY16 | 44.6% | −36% |
| FY15 | −34.8% | −37.8% |
| FY14 | −1997.7% | −35.5% |
| FY13 | −3766.6% | −37.1% |
| FY12 | −330.3% | −29.1% |
| FY11 | −470.6% | −27.9% |